| 期刊ISSN: | 0960-8931 | ||
|---|---|---|---|
| E-ISSN: | 1473-5636 | 期刊级别: | |
| 影响因子: | 1.5 | 检索数据库: | |
| 自引率: | 6.7% | 出版语言: | 英文 |
| 出版信息 | |
|---|---|
| 出版社 | Lippincott Williams and Wilkins Ltd. |
| 期刊官网 | http://journals.lww.com/melanomaresearch/pages/default.aspx |
| 涉及的研究方向 | 医学、皮肤病学 |
| 年文章数 | 0 |
| 是否OA | 否 |
| APC费用 | |
| SCI期刊收录coverage | |
| 期刊简介 |
|---|
|
????????????Melanoma Research is a well established international forum for the dissemination of new findings relating to melanoma. The aim of the Journal is to promote the level of informational exchange between those engaged in the field. Melanoma Research aims to encourage an informed and balanced view of experimental and clinical research and extend and stimulate communication and exchange of knowledge between investigators with differing areas of expertise. This will foster the development of translational research. The reporting of new clinical results and the effect and toxicity of new therapeutic agents and immunotherapy will be given emphasis by rapid publication of Short Communications. ??Thus, Melanoma Research seeks to present a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma.
|
| 最新中科院SCI期刊分区 (基础版) |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 最新中科院SCI期刊分区 (升级版) |
|
| Cite Score相关 | ||||
|---|---|---|---|---|
| Cite Score | Cite Score | SJR | SNIP | 排名 |
EI Compendex
第三届网络、通信与信息技术国际会议(NetCIT2025)多届检索
院士出席
高届数会议
院士出席
无征稿,EI Compendex
2025年遥感与信息技术国际学术会议(RSITTTT2025)多届检索
院士出席
EI Compendex
2024智能计算与机器人国际会议EI Compendex,无征稿,Scopus
往届EI检索|第二届可再生能源技术与电气工程国际学术会议(RETEE2025)EI Compendex
第六届应用机器学习国际会议EI Compendex
能源/环境领域EI期刊征稿EI Compendex
第三届算法、计算和机器学习国际会议(CACML2025)